Historique
Journal of Psychopharmacology, Vol.19, n°1. - 2005
| Titre : | Journal of Psychopharmacology, Vol.19, n°1. - 2005 |
| Type de document : | Bulletin |
| Paru le : | 01/01/2005 |
Dépouillements
Ajouter le résultat à votre sélection
The recent announcements by Synthelabo-Sanofi that their cannabis (CB1) receptor antagonist Rimonabant has shown efficacy in treating obesity and improving lipid profiles, as well as in assisting in smoking cessation (Anthenelli and Despres, 200[...]
H. R. SUMNALL ;
J. C. COLE
|
2005
Dans Journal of Psychopharmacology (Vol.19, n°1, 2005) Article : Périodique
Dans Journal of Psychopharmacology (Vol.19, n°1, 2005) Article : Périodique
National drugs information strategies convey the message that use of Ecstasy is associated with an increase in both the incidence and severity of major depressive disorder. However, very little primary research supports this. Unlike apparent def[...]
J. C. COLE ;
H. R. SUMNALL ;
G. W. SMITH ;
ROSTAMI-HODJEGAN A.
|
2005
Dans Journal of Psychopharmacology (Vol.19, n°1, 2005) Article : Périodique
Dans Journal of Psychopharmacology (Vol.19, n°1, 2005) Article : Périodique
Adverse reactions to polysubstance misuse are common in nightclubs, yet little is known of the physiological effects of polysubstance misuse in this environment. This study examined the heart rate, blood pressure and oral temperature of 50 parti[...]